Quotes EOM Pharmaceuticals Holdings, Inc.
Equities
IMUC
US4525364026
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.21 USD | +40.00% | +14.13% | -9.48% |
Quotes 5-day view
Delayed Quote OTC Markets08/05/2024 | 09/05/2024 | 10/05/2024 | |
---|---|---|---|
Last | 0.21 $ | 0.15 $ | 0.21 $ |
Volume | 168 | 5 000 | 100 |
Change | +∞% | -28.57% | +40.00% |
Opening | 0.21 | 0.15 | 0.21 |
High | 0.21 | 0.15 | 0.21 |
Low | 0.21 | 0.15 | 0.21 |
Performance
1 day | +40.00% | ||
1 week | +14.13% | ||
Current month | +6.11% | ||
1 month | +47.78% | ||
3 months | -27.59% | ||
6 months | -36.34% | ||
Current year | -9.48% | ||
1 year | -40.00% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+40.00% | +14.13% | -9.48% | -40.00% | 23.79M | ||
+7.13% | +2.90% | +26.37% | -2.81% | 44.96B | ||
-2.15% | +0.88% | -1.01% | +21.71% | 42.65B | ||
-1.86% | -0.39% | +46.00% | -10.13% | 41.85B | ||
-1.09% | +0.95% | -5.31% | +14.53% | 29.04B | ||
-1.86% | -1.79% | +9.34% | +54.76% | 26.08B | ||
-0.39% | -0.88% | -21.69% | -27.01% | 19.03B | ||
+1.31% | +7.77% | +6.23% | +0.82% | 12.75B | ||
-0.24% | -2.86% | +26.99% | +86.30% | 12.06B | ||
+0.13% | -2.92% | -3.38% | +19.44% | 11.75B | ||
+0.03% | +1.47% | +20.21% | +23.51% | 11.72B | ||
+1.65% | +4.11% | -0.99% | -4.63% | 9.67B | ||
+0.78% | +3.89% | +29.31% | -10.77% | 6.9B | ||
-3.37% | -6.59% | +4.93% | -35.36% | 6.7B | ||
+1.27% | +1.69% | +17.14% | +100.02% | 6.68B | ||
-0.21% | -4.81% | +29.60% | +43.68% | 6.15B | ||
Average | +2.57% | +0.05% | +10.89% | +14.63% | ||
Weighted average by Cap. | +0.30% | +0.31% | +13.43% | +13.36% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -9.48% | ||
2023 | -71.70% | ||
2022 | +95.17% | ||
2021 | -17.65% |
- Stock Market
- Equities
- IMUC Stock
- Quotes EOM Pharmaceuticals Holdings, Inc.